OncoCyte (OCX) SEC Filings & 10K Form

$2.46
-0.05 (-1.99%)
(As of 04:00 PM ET)

Recent OncoCyte SEC Filings

DateFilerForm TypeView
04/22/2024
12:30 PM
BIO-RAD LABORATORIES, INC. (Filed by)
BIO-RAD LABORATORIES, INC. (Filed by)
OncoCyte (Subject)
Form SC 13G
04/15/2024
8:55 PM
OncoCyte (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
04/15/2024
6:21 PM
BRADSHER NEAL C (Reporting)
BROADWOOD CAPITAL INC (Reporting)
BROADWOOD PARTNERS, L.P. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
6:26 PM
BROADWOOD PARTNERS, L.P. (Filed by)
OncoCyte (Subject)
Form SC 13D/A
04/15/2024
5:02 AM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/15/2024
5:04 AM
OncoCyte (Issuer)
Riggs Josh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/12/2024
5:04 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
4:28 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:47 PM
AWM Investment Company, Inc. (Filed by)
OncoCyte (Subject)
Form SC 13G/A
01/23/2024
3:39 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/09/2023
4:19 PM
OncoCyte (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2023
6:05 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
3:30 PM
Liu James Yang (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2023
3:48 PM
OncoCyte (Filer)
Form 8-K/A
10/05/2023
3:05 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2023
3:05 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/20/2023
8:00 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/17/2023
5:57 PM
OncoCyte (Issuer)
Riggs Josh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2023
6:05 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/24/2023
4:28 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
4:16 PM
OncoCyte (Filer)
Form DEFA14A
07/14/2023
5:03 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2023
10:20 AM
OncoCyte (Filer)
Form DEF 14A
07/03/2023
5:00 PM
Gutfreund John Peter (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/30/2023
3:14 PM
OncoCyte (Filer)
Form PRE 14A
06/27/2023
8:30 PM
OncoCyte (Issuer)
SILVERMAN LOU (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
8:30 PM
KINGSLEY ALFRED D (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
8:30 PM
Last Andrew J. (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2023
8:30 PM
Arno Andrew (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
7:13 PM
KINGSLEY ALFRED D (Reporting)
OncoCyte (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/13/2023
3:05 PM
OncoCyte (Issuer)
Riggs Josh (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
4:12 PM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/22/2023
8:00 AM
OncoCyte (Filer)
Form DEFR14A
05/11/2023
7:05 AM
OncoCyte (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:OCX) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners